European Association for the Study of Obesity May 15 2026 A meta-analysis of 32 studies and 43,618 adults presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) shows that use of new classes of obesity drugs for weight loss is associated with a clinically relevant drop in blood pressure (BP): a 0.34 mmHg reduction in systolic BP per 1 % weight loss. The study is by Dr Marcel Muskiet at the Leiden University Medical Center, Leiden, The Netherlands, and Professor